(Q35930932)

11 August 2017

1 reference

title

Assessing breast cancer risk: genetic factors are not the whole story (English)

1 reference

11 August 2017

Larissa A Korde

1

1 reference

11 August 2017

Kathleen A Calzone

series ordinal

2

1 reference

11 August 2017

JoAnne Zujewski

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 2004

1 reference

11 August 2017

published in

Postgraduate Medicine

1 reference

11 August 2017

volume

116

1 reference

11 August 2017

issue

4

1 reference

11 August 2017

page(s)

6-8, 11-4, 19-20

1 reference

11 August 2017

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Genetics and the Management of Women at High Risk for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

The concise handbook of family cancer syndromes. Mayo Familial Cancer Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Very high risk of cancer in familial Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Management of the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Historical and epidemiologic background of human premalignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Behavioral risk factors in breast cancer: can risk be modified?

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Physical Activity and Cancer Prevention???Data from Epidemiologic Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Oral contraceptives and the risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Second primary breast cancer after Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Validation studies for models projecting the risk of invasive and total breast cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Application of breast cancer risk prediction models in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Progress in chemoprevention of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2004.10.1595

21 January 2018

Identifiers

DOI

10.3810/PGM.2004.10.1595

1 reference

11 August 2017

1 reference